Curated Business & Technology News from Around the Internet

Propanc Biopharma Secures $4 Million Funding to Advance Cancer Stem Cell Research
Propanc Biopharma's successful $4 million public offering accelerates development of pancreatic proenzyme therapy targeting cancer recurrence and metastasis in solid tumors.